Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 2896 AL 2910

Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series

Vrillon A, Deramecourt V, Pasquier F, Magnin É, Wallon D, Lozeron P, Bouaziz-Amar É, Paquet C.

J Alzheimers Dis. 2021;84(4):1439-1446. doi: 10.3233/JAD-215226.

Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's Disease

Wattmo C, Blennow K, Hansson O.

Curr Alzheimer Res. 2021;18(7):573-584. doi: 10.2174/1567205018666211022164952.

A Review of Methods of Diagnosis and Complexity Analysis of Alzheimer's Disease Using EEG Signals

Ouchani M, Gharibzadeh S, Jamshidi M, Amini M.

Biomed Res Int. 2021 Oct 27;2021:5425569. doi: 10.1155/2021/5425569. eCollection 2021.

Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial

Lin PY, Cheng C, Satyanarayanan SK, Chiu LT, Chien YC, Chuu CP, Lan TH, Su KP.

Brain Behav Immun. 2022 Jan;99:289-298. doi: 10.1016/j.bbi.2021.10.014. Epub 2021 Oct 29.

Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)

Pajewski NM, Elahi FM, Tamura MK, Hinman JD, Nasrallah IM, Ix JH, Miller LM, Launer LJ, Wright CB, Supiano MA, Lerner AJ, Sudduth TL, Killeen AA, Cheung AK, Reboussin DM, Wilcock DM, Williamson JD.

Alzheimers Dement. 2022 Aug;18(8):1472-1483. doi: 10.1002/alz.12496. Epub 2021 Nov 17.

Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis

Anita NZ, Zebarth J, Chan B, Wu CY, Syed T, Shahrul D, Nguyen MM, Pakosh M, Herrmann N, Lanctôt KL, Swardfager W.

Brain Behav Immun. 2022 Feb;100:55-69. doi: 10.1016/j.bbi.2021.11.005. Epub 2021 Nov 20.

Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration

Gijs M, Ramakers IHGB, Visser PJ, Verhey FRJ, van de Waarenburg MPH, Schalkwijk CG, Nuijts RMMA, Webers CAB.

Sci Rep. 2021 Nov 22;11(1):22675. doi: 10.1038/s41598-021-01993-x.

[Depression and its relationship with mild cognitive impairment and Alzheimer disease: A review study]

González Hernández A, Rodríguez Quintero AM, Bonilla Santos J.

Rev Esp Geriatr Gerontol. 2022 Mar-Apr;57(2):118-128. doi: 10.1016/j.regg.2021.10.002. Epub 2021 Nov 27.

Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects

Tumati S, Herrmann N, Marotta G, Li A, Lanctôt KL.

Neurochem Int. 2022 Jan;152:105250. doi: 10.1016/j.neuint.2021.105250. Epub 2021 Dec 2.

Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease-Related Decline

Cullen N, Janelidze S, Palmqvist S, Stomrud E, Mattsson-Carlgren N, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

Neurology. 2022 Mar 1;98(9):e958-e967. doi: 10.1212/WNL.0000000000013228. Epub 2021 Dec 22.

A case report of late-onset schizophrenia differentiated from a dementing disorder

Shimada T, Uehara T, Nagasawa T, Hasegawa M, Maeda Y, Kawasaki Y.

Neurocase. 2021 Dec;27(6):467-473. doi: 10.1080/13554794.2021.2016858. Epub 2021 Dec 23.

Diabetes and cognitive decline

Bellia C, Lombardo M, Meloni M, Della-Morte D, Bellia A, Lauro D.

Adv Clin Chem. 2022;108:37-71. doi: 10.1016/bs.acc.2021.07.006. Epub 2021 Aug 23.

Psychophysiological Effects of Dance Movement Therapy and Physical Exercise on Older Adults With Mild Dementia: A Randomized Controlled Trial

Ho RTH, Fong TCT, Chan WC, Kwan JSK, Chiu PKC, Yau JCY, Lam LCW.

J Gerontol B Psychol Sci Soc Sci. 2020 Feb 14;75(3):560-570. doi: 10.1093/geronb/gby145.

Computerized Cognitive Training for Older Adults at Higher Dementia Risk due to Diabetes: Findings From a Randomized Controlled Trial

Bahar-Fuchs A, Barendse MEA, Bloom R, Ravona-Springer R, Heymann A, Dabush H, Bar L, Slater-Barkan S, Rassovsky Y, Schnaider Beeri M.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):747-754. doi: 10.1093/gerona/glz073.

Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) tool

Griffiths AW, Albertyn CP, Burnley NL, Creese B, Walwyn R, Holloway I, Safarikova J, Surr CA.

Int Psychogeriatr. 2020 Jan;32(1):75-85. doi: 10.1017/S1041610219000279.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias